INNOPEUTICS Trademark

Trademark Overview

On Thursday, December 18, 2025, a trademark application was filed for INNOPEUTICS with the United States Patent and Trademark Office. The USPTO has given the INNOPEUTICS trademark a serial number of 79445256. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, April 21, 2026. This trademark is owned by INNOPEUTICS corporation. The INNOPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes, namely, for the treatment ...
innopeutics

General Information

Serial Number79445256
Word MarkINNOPEUTICS
Filing DateThursday, December 18, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, April 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 23, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINNOPEUTICS corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Thursday, March 5, 2026SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, March 23, 2026LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, March 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 23, 2026APPLICATION FILING RECEIPT MAILED
Tuesday, April 21, 2026ASSIGNED TO EXAMINER

Related Keywords

innopeutics preparations pharmaceutical treatment system cancer diseases viral disorders nervous musculoskeletal